We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SkyePharma, Kos to Develop Asthma Treatment
SkyePharma, Kos to Develop Asthma Treatment
May 8, 2006
SkyePharma has entered into an agreement with Kos Pharmaceuticals to jointly develop and market Flutiform, which the company believes could be a $1 billion-a-year new asthma treatment.